Cellcept

Cellcept (Mycophenolate Mofetil) is an immunosuppressant used to prevent organ rejection after transplants. This intravenous medication helps manage immune responses in transplant patients.

Cellcept (Mycophenolate Mofetil) is primarily used to prevent rejection in organ transplant patients. It works by suppressing the immune system to help the body accept the new organ. This medication is often prescribed for kidney, heart, or liver transplants. Patients should follow their healthcare provider's guidance for proper use.

Common effects of Cellcept may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some patients may also experience fatigue or an increased risk of infections due to its immunosuppressant properties. Always consult a healthcare provider for personalized advice.

Cellcept should be handled with care, especially by those with a history of severe infections or gastrointestinal disorders. It is important to follow proper hygiene practices to reduce the risk of infections. Pregnant women should discuss the use of Cellcept with their healthcare provider due to potential risks.

Cellcept may interact with other medications, including certain antiviral drugs and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution.